. 2011 Nov 28;33(1):66–74. doi: 10.1038/aps.2011.136

Table 4. Values of serum bone markers after genistein treatment. Mean±SEM. ^bP<0.05, ^cP<0.01 vs control group. ^eP<0.05, ^fP<0.01 vs low dose (10 mg/kg) genistein-treatment groups.

Parameters	Control group	Genistein (10 mg/kg)	Genistein (50 mg/kg)
b-ALP (U/L)	118.00±9.90	151.33±9.01^c	98.93±13.02^bf
OC (ng/mL)	9.95±1.27	13.93±2.55^c	7.76±1.73^bf
OPG (pg/mL)	335.24±18.50	403.67±19.36^c	255.64±23.14^cf
sRANKL (pg/mL)	22.53±3.18	13.15±2.17^c	11.64±2.56^c
CTX (ng/mL)	53.93±7.49	49.40±8.07	38.46±6.62^ce

b-ALP, bone alkaline phosphatase; sRANKL, soluble receptor activator of nuclear factor κB ligand.

Table 4. Values of serum bone markers after genistein treatment. Mean±SEM. bP<0.05, cP<0.01 vs control group. eP<0.05, fP<0.01 vs low dose (10 mg/kg) genistein-treatment groups.